|
SearchBreast Cancer: Free Medical and Health Information on Breast Cancer Research and TreatmentBreast Cancer
Search within these results:
Epidermal growth factor receptor (EGFR) and HER3 each form heterodimers with HER2 and have independently been implicated as key coreceptors that drive HER2-amplified breast cancer.
San Francisco, CA 94080 USA PURPOSE: HER-2/neu is overexpressed in breast cancer and is the source of immunogenic peptides.
3851 Roger Brooke Dr
Houston, TX 78234 USA Design, synthesis, and evaluation of novel mutual prodrugs (hybrid drugs) of all-trans-retinoic acid
Novel mutual prodrugs (MPs) of ATRA (all- trans-retinoic acid) and HDIs (histone deacetylase inhibitors) ( 10, 13, 17- 19) connected via glycine acyloxyalkyl carbamate linker (AC linker) or through a benzyl ester linker (1,6-elimination linker) were rationally designed and synthesized.
685 West Baltimore Street
Baltimore, MD 21201-1559 USA BACKGROUND: New developments in the search for susceptibility alleles in complex disorders provide support for the possibility of a polygenic approach to the prevention and treatment of common diseases.
UK Androgens have a dual effect on mammary cells.
1, place de l'Hôpital, 67091 Strasbourg
France One of the most significant accomplishments of translational oncogenomics is a realistic promise of efficient diagnostic tests that would facilitate implementation of the concept of individualized cancer therapies.
150 New Scotland Ave.
Albany, NY 12208 USA One of the most significant accomplishments of translational oncogenomics is a realistic promise of efficient diagnostic tests that would facilitate implementation of the concept of individualized cancer therapies.
PO Box 2900
Durham, NC 27710 USA Recent research in breast biology has provided support for the cancer stem-cell hypothesis.
Ann Arbor, MI 48109-5942 USA Absolute Risk Reductions for Local Recurrence After Postoperative Radiotherapy After Sector Resectio
PURPOSE: Evaluate the effects of radiotherapy after sector resection for ductal carcinoma in situ of the breast (DCIS) in patient groups as defined by age, size of the lesion, focality, completeness of excision and mode of detection.
London, UK UK Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cance
PURPOSE: Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) expression.
Villejuif, France France |
PartnersLinksApproved By
|